ESR1 and breast carcinoma: The cholesterol metabolite, 27-hydroxycholesterol (27HC), has been shown to support tumour cell growth in models of estrogen receptor positive luminal breast cancer [91] and increase metastatic activity in mouse models of breast cancer [92].